Rs.250 Million New Pharmaceuticals Products Mfg. Expansion Project in YSR, Andhra Pradesh
A pharmaceutical company plans to expand its manufacturing capacity for various medications in Andhra Pradesh. The project includes increased production of acyclovir, sertraline hydrochloride, lamotrigine, venlafaxine hydrochloride, rosuvastatin TBA salt, and remdesivir intermediates. The estimated cost is Rs. 250 million, and the company has obtained consent from pollution control authorities as of May 2023.
View project